Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.EIGR · Entity 16554 | Director | March 01, 2023 | March 04, 2023 |
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | EVP Chief Patient & Ext Af Off | July 21, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Eiger BioPharmaceuticals, Inc.
Report date March 01, 2023 · Filed March 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.71 · Expires 2033-02-28 | Direct | 28,000 |
Reported balance
After 2023-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-01 · Grant · Acquired 28,000 · Balance 28,000 F1: The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date.
VERTEX PHARMACEUTICALS INC / MA
Report date July 21, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,512 |
Reported balance
After 2026-07-21 transaction · row 1
1 source rowRow 1 · 2026-07-21 · Grant · Acquired 8,251 · Balance 66,512 F1: Restricted stock unit award that vests on 03/31/2030. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 882 |
Reported balance
Holding disclosure · report date 2026-07-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 882 |
| Common StockSEC Table I · non-derivative | IndirectHeld in Trust | 6,637 |
Reported balance
Holding disclosure · report date 2026-07-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,637 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit award that vests on 03/31/2030.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2014 Filed Oct 1, 2014 21:14 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 28,594 | $37.86 | $1,082,568.84 |
DisclosureSEC source: 0001209191-14-060588 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:14 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 40,031 | $38.80 | $1,553,202.80 |
DisclosureSEC source: 0001209191-14-060588 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:14 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,500 | $33.82 | $355,110.00 |
DisclosureSEC source: 0001209191-14-060588 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:14 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 4,375 | $39.05 | $170,843.75 |
DisclosureSEC source: 0001209191-14-060588 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:14 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 2,500 | $33.28 | $83,200.00 |
DisclosureSEC source: 0001209191-14-060588 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2014 Filed Jul 17, 2014 22:32 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 27,500 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-14-047911 · doc4.xml · derivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2024-07-14 F1 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/15/2014. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · derivative · entry 8 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 20,000 shares Expires 2020-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/14/2010. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $33.28 | $0.00 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · derivative · entry 7 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 7,000 shares Expires 2019-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option (right to buy) · Derivative | 15,250 | $0.00 Strike: $33.55 | $0.00 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · derivative · entry 6 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,250 shares Expires 2019-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 42,250 | $98.03 | $4,141,767.50 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,671 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 20,000 | $33.82 | $676,400.00 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,000 | $33.28 | $232,960.00 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2014 Filed Jun 26, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 15,250 | $33.55 | $511,637.50 |
DisclosureSEC source: 0001209191-14-043889 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantEmployee Stock Option (right to buy) · Derivative | 41,250 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-14-008358 · doc4.xml · derivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 41,250 shares Expires 2024-02-04 F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/5/2014. Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 21:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 11,875 | $0.01 | $118.75 |
DisclosureSEC source: 0001209191-14-008358 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,436 F1 · shares: Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2018, subject to (i) acceleration of 50% of shares upon (a) reaching a specified net product sales level over a one-year period for a combination regimen that includes ivacaftor and a CFTR corrector or (b) dosing of the first patient in the first clinical trial to evaluate a second-generation CFTR corrector compound and (ii) acceleration of 50% of shares upon (a) dosing of the first patient in a pivotal trial for a regimen including VX-661 or a specified cancer compound or (b) reaching a specified net product sales level over a one-year period for all our products. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,542 | $65.47 | $166,424.74 |
DisclosureSEC source: 0001209191-13-056701 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,561 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.47 (range $65.06 to $65.93). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 30, 2013 Filed Aug 1, 2013 20:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 27,500 | $0.00 Strike: $83.36 | $0.00 |
DisclosureSEC source: 0001209191-13-038694 · doc4.xml · derivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2023-07-29 F1 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/30/2013. Read SEC document |
| July 19, 2013 Filed Jul 23, 2013 20:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 15,250 | $0.00 Strike: $33.55 | $0.00 |
DisclosureSEC source: 0001209191-13-037574 · doc4.xml · derivative · entry 7 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,250 Underlying: Common Stock · 15,250 shares Expires 2019-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 19, 2013 Filed Jul 23, 2013 20:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7,000 | $0.00 Strike: $33.28 | $0.00 |
DisclosureSEC source: 0001209191-13-037574 · doc4.xml · derivative · entry 6 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 7,000 shares Expires 2019-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 19, 2013 Filed Jul 23, 2013 20:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 15,250 | $89.00 | $1,357,250.00 |
DisclosureSEC source: 0001209191-13-037574 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,987 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2013 Filed Jul 23, 2013 20:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 7,000 | $88.00 | $616,000.00 |
DisclosureSEC source: 0001209191-13-037574 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,237 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 19, 2013 Filed Jul 23, 2013 20:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 15,250 | $33.55 | $511,637.50 |
DisclosureSEC source: 0001209191-13-037574 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2013 Filed Jul 23, 2013 20:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,000 | $33.28 | $232,960.00 |
DisclosureSEC source: 0001209191-13-037574 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 30,500 | $0.00 Strike: $33.55 | $0.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · derivative · entry 11 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2019-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7,000 | $0.00 Strike: $33.28 | $0.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · derivative · entry 10 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 7,000 shares Expires 2019-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/16/2009. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 15,250 | $87.00 | $1,326,750.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 7 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,987 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 7,000 | $86.00 | $602,000.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,237 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 15,250 | $85.00 | $1,296,250.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,237 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,000 | $33.28 | $232,960.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 30,500 | $33.55 | $1,023,275.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7,000 | $0.00 Strike: $33.28 | $0.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · derivative · entry 9 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500 Underlying: Common Stock · 7,000 shares Expires 2019-07-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/16/2009. Read SEC document |
| July 11, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 7,000 | $84.00 | $588,000.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,987 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 11, 2013 Filed Jul 15, 2013 20:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7,000 | $33.28 | $232,960.00 |
DisclosureSEC source: 0001209191-13-036630 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2013 Filed Jul 9, 2013 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 60,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001209191-13-035982 · doc4.xml · derivative · entry 7 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2019-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| July 05, 2013 Filed Jul 9, 2013 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 1,907 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001209191-13-035982 · doc4.xml · derivative · entry 6 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,907 shares Expires 2018-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| July 05, 2013 Filed Jul 9, 2013 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 47,507 | $81.45 | $3,869,445.15 |
DisclosureSEC source: 0001209191-13-035982 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,987 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $81.45 (range $81.00 to $81.86). Read SEC document |
| July 05, 2013 Filed Jul 9, 2013 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 14,400 | $80.65 | $1,161,360.00 |
DisclosureSEC source: 0001209191-13-035982 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,494 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $80.65 (range $80.25 to $80.99). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 05, 2013 Filed Jul 9, 2013 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 60,000 | $33.00 | $1,980,000.00 |
DisclosureSEC source: 0001209191-13-035982 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2013 Filed Jul 9, 2013 20:15 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,907 | $32.16 | $61,329.12 |
DisclosureSEC source: 0001209191-13-035982 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2013 Filed Feb 7, 2013 22:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantEmployee Stock Option (right to buy) · Derivative | 45,750 | $0.00 Strike: $45.11 | $0.00 |
DisclosureSEC source: 0001209191-13-007130 · doc4.xml · derivative · entry 3 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,750 Underlying: Common Stock · 45,750 shares Expires 2023-02-04 F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013. Read SEC document |
| February 05, 2013 Filed Feb 7, 2013 22:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 10,166 | $0.01 | $101.66 |
DisclosureSEC source: 0001209191-13-007130 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,987 F1 · shares: Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2017, subject to (i) acceleration of 50% of shares upon (a) receiving filing confirmation for an NDA for a combination regimen that includes both ivacaftor and a corrector compound or (b) receiving filing confirmation for an sNDA that would increase the number of patients with CF eligible for ivacaftor monotherapy, and (ii) acceleration of 50% of shares upon (a) the announcement of proof-of-concept data for a drug candidate other than an HCV, cystic fibrosis, influenza or JAK3 inhibition drug candidate or (b) reaching a specified net sales level over a twelve month period for our CF products. Read SEC document |
| November 16, 2012 Filed Nov 20, 2012 21:18 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,287 | $41.29 | $94,430.23 |
DisclosureSEC source: 0001209191-12-054063 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,821 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $41.29 (range $41.04 to $41.82). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2012 Filed Sep 25, 2012 20:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,531 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001209191-12-046638 · doc4.xml · derivative · entry 4 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,907 Underlying: Common Stock · 9,531 shares Expires 2018-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 21, 2012 Filed Sep 25, 2012 20:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 9,531 | $59.00 | $562,329.00 |
DisclosureSEC source: 0001209191-12-046638 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,108 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| September 21, 2012 Filed Sep 25, 2012 20:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 9,531 | $32.16 | $306,516.96 |
DisclosureSEC source: 0001209191-12-046638 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 20:26 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,531 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001209191-12-045738 · doc4.xml · derivative · entry 10 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,438 Underlying: Common Stock · 9,531 shares Expires 2018-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 20:26 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 9,531 | $58.00 | $552,798.00 |
DisclosureSEC source: 0001209191-12-045738 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,108 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 20:26 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 9,531 | $32.16 | $306,516.96 |
DisclosureSEC source: 0001209191-12-045738 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 20:26 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,531 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001209191-12-045738 · doc4.xml · derivative · entry 9 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,969 Underlying: Common Stock · 9,531 shares Expires 2018-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 20:26 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $29.25 | $0.00 |
DisclosureSEC source: 0001209191-12-045738 · doc4.xml · derivative · entry 8 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires 2017-07-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.